GORE German Office Real Estate AG
- WKN: A0Z26C
- ISIN: DE000A0Z26C8
- Land: Deutschland
Nachricht vom 02.06.2021 | 09:36
GORE German Office Real Estate AG: GORE: Commercial property successfully sold in Grafing near Munich
DGAP-News: GORE German Office Real Estate AG
/ Key word(s): Real Estate/Miscellaneous
GORE: Commercial property successfully sold in Grafing near Munich
Frankfurt/Main, 02 June 2021 - GORE German Office Real Estate AG ("GORE"; ISIN DE000A0Z26C8) has successfully sold a commercial property in Grafing. The property covering more than 4,000 square metres is located in the economically strong surroundings of Munich, which is about 30 kilometres from the Bavarian capital. The entire property is let to Nuvisan, an internationally active research institute.
The parties have agreed not to disclose the buyer or the purchase price. The transaction involves publity AG ("publity"; ISIN DE0006972508) in its capacity as asset manager for GORE and Neopolis Advisory from Berlin. publity acquired the commercial property in 2018 and has developed it continuously since then: In November 2020, Nuvisan had extended the tenancy agreement until 2035.
Jörg Reinhardt, CEO of GORE: "The sale of the commercial property in Grafing underpins
Frank Schneider, Chief Executive Officer at publity: "Despite the Corona pandemic, we managed to successfully develop the property in Grafing. Among other things, we optimised the tenancy agreement and extended the contract of the main tenant Nuvisan for another 15 years. The successful sale to a suitable buyer shows how strong our network is, especially in a challenging environment."
|Company:||GORE German Office Real Estate AG|
|Bockenheimer Landstraße 17-19|
|60325 Frankfurt am Main|
|Phone:||069 / 2714 74 038|
|Listed:||Regulated Unofficial Market in Frankfurt, Munich (m:access)|
|EQS News ID:||1203534|
|End of News||DGAP News Service|
GORE German Office Real Estate AG: almost bala ...
GORE German Office Real Estate AG sells commer ...
GORE German Office Real Estate AG plans realig ...
GORE German Office Real Estate AG: Shareholder ...
GORE German Office Real Estate AG: GORE: Comme ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
06. Dezember 13:15 Bitcoin: "High-Risk" und "Chance auf 100.000 Dollar"
06. Dezember 13:45 Munich Re: Das schaut viel besser aus
06. Dezember 14:15 Allianz dealt mit BASF – Aktie hat Rückenwind
06. Dezember 14:15 Deutsche Nebenwerte: Starke Aussichten
06. Dezember 14:18 Thyssenkrupp auf Talfahrt - das macht Hoffnung auf die Trendwende
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: PSI AG (von First Berlin Equity Research GmbH): Hinzufügen
06. Dezember 2021